Cargando…
Impact of a Clinical Decision Model for Febrile Children at Risk for Serious Bacterial Infections at the Emergency Department: A Randomized Controlled Trial
OBJECTIVES: To assess the impact of a clinical decision model for febrile children at risk for serious bacterial infections (SBI) attending the emergency department (ED). METHODS: Randomized controlled trial with 439 febrile children, aged 1 month-16 years, attending the pediatric ED of a Dutch univ...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4449197/ https://www.ncbi.nlm.nih.gov/pubmed/26024532 http://dx.doi.org/10.1371/journal.pone.0127620 |
_version_ | 1782373826212921344 |
---|---|
author | de Vos-Kerkhof, Evelien Nijman, Ruud G. Vergouwe, Yvonne Polinder, Suzanne Steyerberg, Ewout W. van der Lei, Johan Moll, Henriëtte A. Oostenbrink, Rianne |
author_facet | de Vos-Kerkhof, Evelien Nijman, Ruud G. Vergouwe, Yvonne Polinder, Suzanne Steyerberg, Ewout W. van der Lei, Johan Moll, Henriëtte A. Oostenbrink, Rianne |
author_sort | de Vos-Kerkhof, Evelien |
collection | PubMed |
description | OBJECTIVES: To assess the impact of a clinical decision model for febrile children at risk for serious bacterial infections (SBI) attending the emergency department (ED). METHODS: Randomized controlled trial with 439 febrile children, aged 1 month-16 years, attending the pediatric ED of a Dutch university hospital during 2010-2012. Febrile children were randomly assigned to the intervention (clinical decision model; n=219) or the control group (usual care; n=220). The clinical decision model included clinical symptoms, vital signs, and C-reactive protein and provided high/low-risks for “pneumonia” and “other SBI”. Nurses were guided by the intervention to initiate additional tests for high-risk children. The clinical decision model was evaluated by 1) area-under-the-receiver-operating-characteristic-curve (AUC) to indicate discriminative ability and 2) feasibility, to measure nurses’ compliance to model recommendations. Primary patient outcome was defined as correct SBI diagnoses. Secondary process outcomes were defined as length of stay; diagnostic tests; antibiotic treatment; hospital admission; revisits and medical costs. RESULTS: The decision model had good discriminative ability for both pneumonia (n=33; AUC 0.83 (95% CI 0.75-0.90)) and other SBI (n=22; AUC 0.81 (95% CI 0.72-0.90)). Compliance to model recommendations was high (86%). No differences in correct SBI determination were observed. Application of the clinical decision model resulted in less full-blood-counts (14% vs. 22%, p-value<0.05) and more urine-dipstick testing (71% vs. 61%, p-value<0.05). CONCLUSIONS: In contrast to our expectations no substantial impact on patient outcome was perceived. The clinical decision model preserved, however, good discriminatory ability to detect SBI, achieved good compliance among nurses and resulted in a more standardized diagnostic approach towards febrile children, with less full blood-counts and more rightfully urine-dipstick testing. TRIAL REGISTRATION: Nederlands Trial Register NTR2381 |
format | Online Article Text |
id | pubmed-4449197 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-44491972015-06-09 Impact of a Clinical Decision Model for Febrile Children at Risk for Serious Bacterial Infections at the Emergency Department: A Randomized Controlled Trial de Vos-Kerkhof, Evelien Nijman, Ruud G. Vergouwe, Yvonne Polinder, Suzanne Steyerberg, Ewout W. van der Lei, Johan Moll, Henriëtte A. Oostenbrink, Rianne PLoS One Research Article OBJECTIVES: To assess the impact of a clinical decision model for febrile children at risk for serious bacterial infections (SBI) attending the emergency department (ED). METHODS: Randomized controlled trial with 439 febrile children, aged 1 month-16 years, attending the pediatric ED of a Dutch university hospital during 2010-2012. Febrile children were randomly assigned to the intervention (clinical decision model; n=219) or the control group (usual care; n=220). The clinical decision model included clinical symptoms, vital signs, and C-reactive protein and provided high/low-risks for “pneumonia” and “other SBI”. Nurses were guided by the intervention to initiate additional tests for high-risk children. The clinical decision model was evaluated by 1) area-under-the-receiver-operating-characteristic-curve (AUC) to indicate discriminative ability and 2) feasibility, to measure nurses’ compliance to model recommendations. Primary patient outcome was defined as correct SBI diagnoses. Secondary process outcomes were defined as length of stay; diagnostic tests; antibiotic treatment; hospital admission; revisits and medical costs. RESULTS: The decision model had good discriminative ability for both pneumonia (n=33; AUC 0.83 (95% CI 0.75-0.90)) and other SBI (n=22; AUC 0.81 (95% CI 0.72-0.90)). Compliance to model recommendations was high (86%). No differences in correct SBI determination were observed. Application of the clinical decision model resulted in less full-blood-counts (14% vs. 22%, p-value<0.05) and more urine-dipstick testing (71% vs. 61%, p-value<0.05). CONCLUSIONS: In contrast to our expectations no substantial impact on patient outcome was perceived. The clinical decision model preserved, however, good discriminatory ability to detect SBI, achieved good compliance among nurses and resulted in a more standardized diagnostic approach towards febrile children, with less full blood-counts and more rightfully urine-dipstick testing. TRIAL REGISTRATION: Nederlands Trial Register NTR2381 Public Library of Science 2015-05-29 /pmc/articles/PMC4449197/ /pubmed/26024532 http://dx.doi.org/10.1371/journal.pone.0127620 Text en © 2015 de Vos-Kerkhof et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article de Vos-Kerkhof, Evelien Nijman, Ruud G. Vergouwe, Yvonne Polinder, Suzanne Steyerberg, Ewout W. van der Lei, Johan Moll, Henriëtte A. Oostenbrink, Rianne Impact of a Clinical Decision Model for Febrile Children at Risk for Serious Bacterial Infections at the Emergency Department: A Randomized Controlled Trial |
title | Impact of a Clinical Decision Model for Febrile Children at Risk for Serious Bacterial Infections at the Emergency Department: A Randomized Controlled Trial |
title_full | Impact of a Clinical Decision Model for Febrile Children at Risk for Serious Bacterial Infections at the Emergency Department: A Randomized Controlled Trial |
title_fullStr | Impact of a Clinical Decision Model for Febrile Children at Risk for Serious Bacterial Infections at the Emergency Department: A Randomized Controlled Trial |
title_full_unstemmed | Impact of a Clinical Decision Model for Febrile Children at Risk for Serious Bacterial Infections at the Emergency Department: A Randomized Controlled Trial |
title_short | Impact of a Clinical Decision Model for Febrile Children at Risk for Serious Bacterial Infections at the Emergency Department: A Randomized Controlled Trial |
title_sort | impact of a clinical decision model for febrile children at risk for serious bacterial infections at the emergency department: a randomized controlled trial |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4449197/ https://www.ncbi.nlm.nih.gov/pubmed/26024532 http://dx.doi.org/10.1371/journal.pone.0127620 |
work_keys_str_mv | AT devoskerkhofevelien impactofaclinicaldecisionmodelforfebrilechildrenatriskforseriousbacterialinfectionsattheemergencydepartmentarandomizedcontrolledtrial AT nijmanruudg impactofaclinicaldecisionmodelforfebrilechildrenatriskforseriousbacterialinfectionsattheemergencydepartmentarandomizedcontrolledtrial AT vergouweyvonne impactofaclinicaldecisionmodelforfebrilechildrenatriskforseriousbacterialinfectionsattheemergencydepartmentarandomizedcontrolledtrial AT polindersuzanne impactofaclinicaldecisionmodelforfebrilechildrenatriskforseriousbacterialinfectionsattheemergencydepartmentarandomizedcontrolledtrial AT steyerbergewoutw impactofaclinicaldecisionmodelforfebrilechildrenatriskforseriousbacterialinfectionsattheemergencydepartmentarandomizedcontrolledtrial AT vanderleijohan impactofaclinicaldecisionmodelforfebrilechildrenatriskforseriousbacterialinfectionsattheemergencydepartmentarandomizedcontrolledtrial AT mollhenriettea impactofaclinicaldecisionmodelforfebrilechildrenatriskforseriousbacterialinfectionsattheemergencydepartmentarandomizedcontrolledtrial AT oostenbrinkrianne impactofaclinicaldecisionmodelforfebrilechildrenatriskforseriousbacterialinfectionsattheemergencydepartmentarandomizedcontrolledtrial |